Our immunology research investigates the complex interactions between immune cells and cancer, focusing on T-cell biology, antigen presentation, and immune checkpoint regulation.

We explore the tumor microenvironment (TME) to understand how cancer-associated fibroblasts, immune cells, and extracellular matrix components interact to promote tumor progression and immune evasion.

Our precision medicine program develops targeted therapies including CAR-T cells, neoantigen-specific treatments, and biomarker-guided interventions.

Leveraging computational biology and machine learning, we analyze large-scale proteomics, transcriptomics, and clinical datasets to discover novel biomarkers and predict drug synergies.